Avstralija - angleščina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - clostridium haemolyticum; clostridium perfringens type b toxoid; clostridium perfringens type c toxoid; clostridium chauvoei whole cell culture; clostridium novyi tybe b toxiod and inactivated cells; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; thiomersal; aluminium (adjuvant) - misc. vaccines or anti sera - clostridium haemolyticum vaccine-toxoid active 21.2 tcp u/ml; clostridium perfringens type b toxoid vaccine-toxoid active 30.6 tcp u/ml; clostridium perfringens type c toxoid vaccine-toxoid active 15.3 tcp u/ml; clostridium chauvoei whole cell culture vaccine-microbial active 30.0 %ferm/ml; clostridium novyi tybe b toxiod and inactivated cells vaccine-toxiod active 5.95 tcp u/ml; clostridium perfringens type d toxoid vaccine-toxoid active 55.3 tcp u/ml; clostridium septicum - toxoid vaccine-toxoid active 6.4 tcp u/ml; clostridium tetani - toxoid vaccine-toxoid active 3.0 lf u/ml; thiomersal mercury other 0.15 mg/ml; aluminium (adjuvant) mineral-aluminium other 0.0 mg/ml - immunotherapy - cattle | lamb | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | hei - black disease | blackleg | dysentery | enterotoxaemia (pulpy kidney) | haemorrhagic enterotoxaemia | malignant oedema | post parturient gangrene | swelled head | tetanus | tick fever - bovine babesiosis | babesia bigemina | babesia bovis | clostridium perfringens type d | red water | redwater | tetanus vaccination

Evropska unija - angleščina - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin

Avstralija - angleščina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - clostridium perfringens type d toxoid; clostridium tetani - toxoid; corynebacterium pseudotuberculosis - toxoid; thiomersal - misc. vaccines or anti sera - clostridium perfringens type d toxoid vaccine-toxoid active 5.0 iu/ml; clostridium tetani - toxoid vaccine-toxoid active 2.5 iu/ml; corynebacterium pseudotuberculosis - toxoid vaccine-toxoid active 1.0 iu/ml; thiomersal mercury other 0.13 g/l - immunotherapy - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - cheesy gland | enterotoxaemia (pulpy kidney) | tetanus | clostridium perfringens type d | lymphadenitis | lymphangitis | tetanus vaccination

Avstralija - angleščina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; thiomersal - misc. vaccines or anti sera - clostridium chauvoei - toxoid vaccine-toxoid active 0.0 u; clostridium novyi type b - toxoid vaccine-toxoid active 3.5 iu/ml; clostridium perfringens type d toxoid vaccine-toxoid active 5.0 iu/ml; clostridium septicum - toxoid vaccine-toxoid active 2.5 iu/ml; clostridium tetani - toxoid vaccine-toxoid active 2.5 iu/ml; thiomersal mercury other 0.13 g/l - immunotherapy - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - black disease | blackleg | enterotoxaemia (pulpy kidney) | malignant oedema | tetanus | vaccine | clostridium perfringens type d | equine rotavirus | tetanus vaccination

Avstralija - angleščina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; sodium hydroxide 30%; thiomersal - misc. vaccines or anti sera - clostridium chauvoei - toxoid vaccine-toxoid active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 0.0 p; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium septicum - toxoid vaccine-toxoid active 0.0 p; clostridium tetani - toxoid vaccine-toxoid active 0.0 p; sodium hydroxide 30% ungrouped other 0.0 qs ph; thiomersal mercury other 0.13 g/l - immunotherapy - cattle | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | heifer | h - black disease | blackleg | enterotoxaemia (pulpy kidney) | malignant oedema | tetanus | clostridium perfringens type d | tetanus vaccination

Velika Britanija - angleščina - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - clostridium chauvoei, clostridium novyi, clostridium perfringens, clostridium septicum, clostridium tetani, mannheimia haemolytica, pasteurella trehalosi - suspension for injection - inactivated bacterial vaccine - sheep

Velika Britanija - angleščina - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - clostridium chauvoei, clostridium novyi, clostridium perfringens, clostridium septicum, clostridium tetani, mannheimia haemolytica, pasteurella trehalosi - suspension for injection - inactivated bacterial vaccine - sheep

Velika Britanija - angleščina - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - clostridium chauvoei, clostridium novyi, clostridium perfringens, clostridium septicum, clostridium tetani, mannheimia haemolytica, pasteurella trehalosi - suspension for injection - inactivated bacterial vaccine - sheep

Evropska unija - angleščina - EMA (European Medicines Agency)

intervet international bv - clostridium-perfringens-type-a alpha toxoid - immunologicals for aves - chicken - for the active immunisation of chickens to provide passive immunisation against necrotic enteritis to their progeny, during the laying period.to reduce mortality and the incidence and severity of lesions caused by clostridium-perfringens-type-a-induced necrotic enteritis. efficacy was demonstrated by challenge of chicks approximately three weeks after hatching.the onset of passive transfer of immunity: 6 weeks following completion of the vaccination procedure.the duration of passive transfer of immunity: 51 weeks following completion of the vaccination procedure.

Irska - angleščina - HPRA (Health Products Regulatory Authority)

intervet ireland limited - clostridium perfringens type d, strain 603 epsilon toxoid, clostridium septicum s1110/85 toxoid, clostridium chauvoei strain no. 655, clostridium chauvoei strain no. 656, clostridium chauvoei strain no. 657, clostridium chauvoei strain no. 658, clostridium chauvoei strain no. 1048, formalin killed cells of mannheimia haemolytica serotypes a1, formalin killed cells of mannheimia haemolytica serotypes a2, formalin killed cells of mannheimia haemolytica serotypes a6, formalin killed cells of mannheimia haemoly - suspension for injection - unknown - clostridium vaccine + pasteurella vaccine - ovine - immunological - inactivated vaccine